An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus

Virology

Volumn 359, Issue 1, 2007, Pages 28-36

  Yuan, Hang ^a   Ghim, Shinje ^b   Newsome, Joe ^c   Apolinario, Tania ^a   Olcese, Vanessa ^a   Martin, Mary ^a   Delius, Hajo ^d   Felsburg, Peter ^e   Jenson, Bennett ^b   Schlegel, Richard ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CfPV 2; COPV; Papillomavirus

Indexed keywords

DOUBLE STRANDED DNA;

ARTICLE; DNA SEQUENCE; DOG; GENE FUNCTION; GENOME; IMMUNE RESPONSE; NONHUMAN; OPEN READING FRAME; PAPILLOMA VIRUS; PLANT GROWTH; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA; VIRUS GENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; DOG DISEASES; DOGS; FOOT; GENOME, VIRAL; HISTOCYTOCHEMISTRY; LAMBDAPAPILLOMAVIRUS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; SEQUENCE HOMOLOGY, NUCLEIC ACID; VIRION;

ANIMALIA; CANINE ORAL PAPILLOMAVIRUS; CANIS FAMILIARIS; PAPILLOMAVIRIDAE;

EID: 33846871486     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.08.029     Document Type: Article

References (34)

1. Androphy E.J., Lowy D.R., and Schiller J.T. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325 6099 (1987) 70-73
2. Bonnez W., Rose R.C., Da Rin C., Borkhuis C., de Mesy Jensen K.L., and Reichman R.C. Propagation of human papillomavirus type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology 197 1 (1993) 455-458
3. Bravo I.G., and Alonso A. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J. Virol. 78 24 (2004) 13613-13626
4. Campbell K.L., Sundberg J.P., Goldschmidt M.H., Knupp C., and Reichmann M.E. Cutaneous inverted papillomas in dogs. Vet. Pathol. 25 1 (1988) 67-71
5. Chen Y., Ghim S.J., Jenson A.B., and Schlegel R. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes. J. Gen. Virol. 79 Pt. 9 (1998) 2137-2146
6. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 1 (2004) 17-27
7. Delius H., Van Ranst M.A., Jenson A.B., zur Hausen H., and Sundberg J.P. Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology 204 1 (1994) 447-452
8. DiMaio D., and Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20 54 (2001) 7866-7873
9. Genther Williams S.M., Disbrow G.L., Schlegel R., Lee D., Threadgill D.W., and Lambert P.F. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65 15 (2005) 6534-6542
10. Goldschmidt M.H., Kennedy J.S., Kennedy D.R., Yuan H., Holt D.E., Casal M.L., Traas A.M., Mauldin E.A., Moore P.F., Henthorn P.S., Hartnett B.J., Weinberg K.I., Schlegel R., and Felsburg P.J. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J. Virol. 80 13 (2006) 6621-6628
11. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., Zahaf T., Innis B., Naud P., De Carvalho N.S., Roteli-Martins C.M., Teixeira J., Blatter M.M., Korn A.P., Quint W., Dubin G., and GlaxoSmithKline H.P.V.V.S.G. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial [see comment]. Lancet 364 9447 (2004) 1757-1765
12. Haugen T.H., Turek L.P., Mercurio F.M., Cripe T.P., Olson B.J., Anderson R.D., Seidl D., Karin M., and Schiller J. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain. EMBO J. 7 13 (1988) 4245-4253
13. Kumar S., and Nei M. MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 5 2 (2004) 150-163
14. Lee S.S., Glaunsinger B., Mantovani F., Banks L., and Javier R.T. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74 20 (2000) 9680-9693
15. Ma T., Zou N., Lin B.Y., Chow L.T., and Harper J.W. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl. Acad. Sci. U. S. A. 96 2 (1999) 382-387
16. Mantovani F., and Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20 54 (2001) 7874-7887
17. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., and Zacny V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 54 (2001) 7888-7898
18. Nakagawa S., and Huibregtse J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20 21 (2000) 8244-8253
19. Narechania A., Terai M., Chen Z., DeSalle R., and Burk R.D. Lack of the canonical pRB-binding domain in the E7 ORF of artiodactyl papillomaviruses is associated with the development of fibropapillomas. J. Gen. Virol. 85 Pt. 5 (2004) 1243-1250
20. Needleman S.B., and Wunsch C.D. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48 3 (1970) 443-453
21. Nguyen M.L., Nguyen M.M., Lee D., Griep A.E., and Lambert P.F. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77 12 (2003) 6957-6964
22. Nicholls P.K., and Stanley M.A. Canine papillomavirus-A centenary review. J. Comp. Pathol. 120 3 (1999) 219-233
23. Shimada A., Shinya K., Awakura T., Narama I., Maeda H., and Umemura T. Cutaneous papillomatosis associated with papillomavirus infection in a dog. J. Comp. Pathol. 108 1 (1993) 103-107
24. Stanley M.A., Moore R.A., Nicholls P.K., Santos E.B., Thomsen L., Parry N., Walcott S., and Gough G. Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. Vaccine 19 20-22 (2001) 2783-2792
25. Sundberg J.P., Smith E.K., Herron A.J., Jenson A.B., Burk R.D., and Van Ranst M. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog. Vet. Pathol. 31 2 (1994) 183-187
26. Suprynowicz F.A., Campo M.S., and Schlegel R. Biological activities of papillomavirus E5 proteins. In: Campo M.S. (Ed). Papillomavirus Research: From Natural History to Vaccine and Beyond (2006), Caister Acedemic Press 97-113
27. Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A., Newsome J.A., Jenson A.B., and Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. U. S. A. 92 25 (1995) 11553-11557
28. Tanabe C., Kano R., Nagata M., Nakamura Y., Watanabe S., and Hasegawa A. Molecular characteristics of cutaneous papillomavirus from the canine pigmented epidermal nevus. J. Vet. Med. Sci. 62 11 (2000) 1189-1192
29. Thomas M., Massimi P., Navarro C., Borg J.P., and Banks L. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24 41 (2005) 6222-6230
30. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 22 (1994) 4673-4680
31. van Ham M., and Hendriks W. PDZ domains-Glue and guide. Mol. Biol. Rep. 30 2 (2003) 69-82
32. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. [see comment]. J. Pathol. 189 1 (1999) 12-19
33. Yuan H., Estes P.A., Chen Y., Newsome J., Olcese V.A., Garcea R.L., and Schlegel R. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J. Virol. 75 17 (2001) 7848-7853
34. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev., Cancer 2 5 (2002) 342-350